[ad_1]
A spokesperson said the case was known and that the problem had been reported to Swissmedic, the drug regulator.
No details or the period from inoculation to death were provided.
The first vaccinations in Switzerland took place in Lucerne last week, and the vaccine developed by Pfizer with German partner BioNTech takes priority for the elderly.
Switzerland, which has so far only approved the use of the Pfizer / BioNTech vaccine, has received 107,000 doses and will receive 250,000 per month next year.
Pfizer and Swissmedic have yet to provide details.
Millions of doses of this vaccine have already been administered in various countries around the world. After administration, several allergic reactions occurred, as in the case of the administration of the vaccine developed by Moderna, but without endangering lives.
If you like this article, we hope you will join the community of readers on our Facebook page, by liking it below:
[ad_2]